The Latest

Company News

June 30, 2022

Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform

Arrow

Read More

Company News

May 19, 2022

Inceptor Bio Announces $37 Million Series A Financing

Arrow

Read More

Company News

December 16, 2021

Inceptor Bio Enters into In-licensing Agreement For CAR-M Platform

Arrow

Read More

Company News

October 27, 2021

Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility And Transfer Operating Team From Arranta Bio

Arrow

Read More

Thought Leadership

July 22, 2021

The Past, Present, and Future of Gene Editing

Arrow

Watch

Company News

July 7, 2021

Inceptor Bio Launches FastBack Bio, Its First Portfolio Company Developing A Novel CAR-T Platform That Targets Difficult-To-Treat Cancers

Arrow

Read More

Thought Leadership

June 23, 2021

Beyond CAR-T: Other Engineered Immune Cells

Arrow

Watch

Company News

June 14, 2021

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

Arrow

Read More

Events

October 19-21, 2021

2021 BIO Investor Forum Digital

Arrow

Book a Meeting

Events

January 10-13, 2022

JP Morgan 40th Annual Healthcare Conference

Arrow

Book a Meeting